Loading company…
Shanghai QuietD Biotechnology develops diagnostic and therapeutic solutions for neurodegenerative diseases.
Shanghai QuietD Biotechnology focuses on diagnosing and treating neurodegenerative disorders, including precision diagnostic methods and therapeutic agents. Its work includes the Sp.Det database screening platform, which studies molecular and cellular mechanisms related to RNA splicing events. Founded in 2020, it is based in Shanghai, China, with a diagnostic reagent testing center in Suzhou. It raised pre-series A funding in May 2024 and Series A funding in December 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in